Clinical Trial Update: Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation trial is investigating hypofractionated stereotactic radiotherapy for brain metastases in patients with non-small cell lung cancer (Stage IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN